House Administration Committee Chairman Bryan Steil has formally invited ActBlue CEO Regina Wallace-Jones to testify at a public hearing on May 19, escalating a multi-committee Republican investigation into how the Democratic fundraising giant handles political donations, and whether its leadership misled Congress about safeguards against foreign money.
Steil, a Wisconsin Republican, sent the letter Thursday, Newsmax reported. The move comes just days after three GOP-led committees pressed ActBlue for additional documents, alleging the organization had failed to turn over key materials.
The hearing request is not an isolated shot across the bow. It sits at the center of a widening congressional probe into whether ActBlue, the nonprofit platform that processes donations for thousands of Democratic candidates and causes, has taken adequate steps to prevent foreign contributions from entering the American political system. And it follows a New York Times report that ActBlue's own legal team cautioned that Wallace-Jones may have misled investigators reviewing those very safeguards.
In the letter posted on the committee's website, Steil laid out the committee's rationale in blunt terms:
"There are outstanding questions about whether and how ActBlue has remedied its 'fundamentally unserious approach to fraud prevention.' Accordingly, the Committee requests your prompt assistance in providing information vital to its oversight and investigatory duties."
That phrase, "fundamentally unserious approach to fraud prevention", was not Steil's invention. He was quoting language already in the investigative record. The fact that the committee chairman chose to highlight it in a formal hearing invitation tells you where Republicans believe this trail leads.
Steil also referenced what he described as ActBlue's incomplete response to a July 2025 committee subpoena. His letter stated that "ActBlue's production to the Committee's July 2025 subpoena was deliberately incomplete." That is a serious allegation, not that the platform was slow or disorganized, but that it deliberately withheld material from a congressional subpoena.
The hearing invitation did not arrive in a vacuum. Last week, Steil joined House Judiciary Committee Chairman Jim Jordan of Ohio and House Oversight Committee Chairman James Comer of Kentucky in pressing ActBlue for more documents. The three chairmen wrote jointly that the organization may have intentionally held back responsive material:
"Given ActBlue's demonstrated history of misleading Congress, there is considerable reason to believe that ActBlue may have deliberately withheld this responsive material to impede our investigation."
Three separate committee chairs, from three separate jurisdictions of oversight, arriving at the same conclusion about one organization's conduct, that is not a fishing expedition. That is a coordinated investigative posture built on what Republicans describe as a pattern of evasion.
The Republican fundraising apparatus has been outpacing Democrats heading into the midterms, which makes the scrutiny of ActBlue's operations all the more consequential. If the platform that powers Democratic small-dollar fundraising at every level is shown to have compliance failures, the political and legal fallout could extend well beyond Capitol Hill.
ActBlue is not taking this quietly. On the same Thursday that Steil sent his hearing invitation, ActBlue attorney Vincent Cohen dispatched his own letter, addressed to Steil, Jordan, and Comer. Cohen accused the Republican chairmen of shifting their demands to fit a political agenda.
Cohen said Republicans were "continually moving the goalpost" and doing so "to suit their political needs." He went further, framing the entire investigation as an attack on Democratic infrastructure. As obtained by Campaigns & Elections, Cohen wrote:
"While ActBlue remains committed to providing relevant information, it is deeply concerned that this latest action constitutes a continued partisan attack on a political opponent at a pivotal moment in the electoral cycle, and that Republican congressional leadership has singled out ActBlue not because of any alleged wrongdoing, but because Republicans see a political advantage to undermining the nonprofit that powers thousands of Democratic candidates and causes at every level."
That is a remarkable statement. Cohen's letter does not dispute the existence of the subpoena, does not deny that documents remain outstanding, and does not address the specific allegation that ActBlue's production was "deliberately incomplete." Instead, it pivots to motive, arguing that Republicans are doing this for political gain.
ActBlue and Wallace-Jones have maintained that the organization "cooperated fully and transparently" with investigators. Wallace-Jones has pushed back against claims that she made false statements to Congress. But the New York Times report, that ActBlue's own lawyers warned she may have misled investigators about the platform's foreign-contribution safeguards, complicates that defense considerably.
When your own legal team raises red flags about your testimony, the "we've been fully transparent" line starts to ring hollow.
At the heart of this probe is a straightforward concern: Are foreign nationals funneling money into American elections through ActBlue's platform? Federal law prohibits foreign contributions to U.S. campaigns. The question is whether ActBlue's fraud-prevention tools are adequate to catch and block such donations, and whether the organization's leadership has been honest with Congress about the state of those tools.
Democrats have dismissed the investigations, including a separate Justice Department inquiry, as politically driven. That is a familiar playbook. When accountability arrives, call it politics. But the presence of a parallel DOJ inquiry suggests the concerns extend beyond congressional Republicans looking for a headline.
The broader pattern of Democratic figures facing legal and ethical pressure only adds weight to the questions surrounding ActBlue's operations. Voters deserve to know whether the single largest small-dollar fundraising platform in Democratic politics has been playing by the rules.
The May 19 hearing date is now on the calendar. What remains unclear is whether Wallace-Jones will actually appear. The letter from Steil was framed as an invitation, but given the committee's subpoena history with ActBlue and the multi-committee pressure campaign, the invitation carries obvious weight. A refusal to testify would almost certainly accelerate the confrontation.
Several questions remain unanswered. What specific materials did ActBlue allegedly withhold from the July 2025 subpoena? What safeguards on foreign contributions were under review when ActBlue's own lawyers raised concerns about Wallace-Jones's statements? And what, precisely, did Wallace-Jones tell investigators that her own legal team found troubling enough to flag?
None of those questions have been publicly resolved. ActBlue's response so far has been to cry partisanship and assert cooperation. But assertions are not evidence, and when three committee chairmen say your document production was deliberately incomplete, the burden shifts.
Meanwhile, Democrats have been busy with their own political maneuvers on Capitol Hill, making it all the more notable that their fundraising backbone is now under formal investigative scrutiny from multiple directions.
The Democratic strategy of dismissing every Republican investigation as a "partisan attack" has a shelf life. It works until the facts pile high enough that the public stops buying it. A New York Times report about internal legal warnings, a July 2025 subpoena allegedly met with incomplete production, and a formal hearing invitation to the CEO, that is not a fishing expedition. That is an investigation with receipts.
Republicans like some Democrats who have promised aggressive oversight of their own understand that congressional hearings are where the public record gets built. If Wallace-Jones sits in that witness chair on May 19, she will face questions under oath. If she refuses, the refusal itself becomes the story.
Either way, the American donor, the retiree who chips in $25 to a candidate and trusts that the platform is keeping foreign money out, deserves a straight answer. So far, ActBlue hasn't provided one.
